July 6, 2021

Winthrop P. Rockefeller Cancer Institute Hosts First Summer Research Intensive for Medical Students

Marty Trieschmann

The NIH-funded Partners in Cancer Research Program is underway at the Winthrop P. Rockefeller Cancer Institute. Second-year medical students learning clinical and in-depth cancer research this summer include (l to r) Nadia Safar, Anna Bragg, Pamela Rosales, Payton Smith, Carl Ramponi, Faizan Cheema, Tom Kelly, M.D. (associate director of Cancer Research and Training), Angel Castro, Robert Kiss, Delanie Mack, Sangeetha Sonney and Claire Keisling. Matthew Newman is not pictured.

New discoveries in cancer treatment might come from 24-year-old Nadia Safar, one of 12 UAMS medical students participating in the state’s first and only undergraduate cancer research program at the Winthrop P. Rockefeller Cancer Institute.  

July 1, 2021

UAMS Neurologist Co-Authors Best Practices Paper for Treating 2 Parkinson’s-related Disorders

Linda Satter

Rohit Dhall, M.D.

LITTLE ROCK — A neurologist at the University of Arkansas for Medical Sciences (UAMS) has co-authored a paper in a leading neurology journal that provides the first best-practices consensus for treating two rare Parkinson’s-related disorders. Rohit Dhall, M.D., a professor of neurology in the College of Medicine and director of neurodegenerative disorders at UAMS, was…

June 29, 2021

UAMS Physicians See Dramatic Increase In Postpartum Psychosis Cases during COVID-19 Pandemic

Tim Taylor

Jessica Coker, M.D., (left) and Erin Bider, M.D., collaborated on a paper detailing the rise in cases of postpartum psychosis they saw at UAMS' Women's Mental Health Program during the COVID-19 pandemic.

LITTLE ROCK — Postpartum psychosis is a serious, albeit rare illness, compared to the number of postpartum depression cases seen in the United States.

June 24, 2021

UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer

David Robinson

UAMS' Hui-Ming Chang, M.D., is leading the Phoenix Trial.

LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…

June 14, 2021

UAMS Project Part of National Effort to Reduce COVID-19 in Hardest Hit Populations

David Robinson

A Marshallese resident in Northwest Arkansas receives a COVID-19 vaccine.

LITTLE ROCK — UAMS researchers and their community partners across Arkansas are studying the causes behind COVID-19’s devastating impact on minorities and developing plans to help increase vaccination rates.

June 4, 2021

Arkansas College Students Learn About COVID-19, Other Infectious Diseases at UAMS-led Workshop

David Robinson

Sumaira Sardar and Finn Beruldsen, students at Hendrix College, attended the Zoom-based infectious diseases career workshop.

UAMS treated Arkansas college students interested in research or medical careers involving infectious diseases like COVID-19 to a workshop May 19.

June 3, 2021

UAMS Donald W. Reynolds Institute on Aging Receives $1.9 Million Grant to Research Link Between Blood Sugar, Alzheimer’s Disease

Karmen Robinson

Steven Barger, Ph.D.

The Donald W. Reynolds Institute on Aging at the University of Arkansas for Medical Sciences (UAMS) has been awarded a five-year, $1.9 million grant from the National Institute on Aging, a division of the National Institutes of Health.

May 11, 2021

UAMS Cancer Researcher Hong-yu Li, Ph.D., Awarded $1.27 Million Grant

Linda Haymes

Hong-yu Li, Ph.D.

LITTLE ROCK — Hong-yu Li, Ph.D., a researcher with the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), recently received a five-year, $1,265,834 grant from the National Institutes of Health and the National Cancer Institute to work toward developing treatment options for acute myeloid leukemia patients. Li, a professor…

May 10, 2021

NIH Grant Supporting UAMS Study of Drugs to Improve Long-term Kidney Transplant Outcomes

David Robinson

UAMS' Nirmala Parajuli, Ph.D., is studying a novel way to improve long-term kidney transplant survival.

LITTLE ROCK — A National Institutes of Health (NIH) grant will allow UAMS researcher Nirmala Parajuli, DVM, Ph.D., to study a novel way to improve the long-term outcomes of patients who receive kidneys from deceased donors. Parajuli, an assistant professor in the College of Medicine Department of Pharmacology and Toxicology, will use the five-year $2.46…

May 7, 2021

UAMS Physician’s New Skills and Lucky Timing Save Vilonia Baby from Deadly, Disabling Disease

David Robinson

Darrell and Elaine Hurst with their two sons, Oliver (left) and Paxton. Oliver was born last year with Spinal Muscular Atrophy, a disease that could have killed him if not for a newborn screening implemented by UAMS’ Kapil Arya, M.D., and a new treatment.

Oliver Hurst owes his life to a luckily timed move across the country. His father and mother, who was then three months pregnant with Oliver, arrived in Vilonia from California in March 2020. At the time, UAMS’ Kapil Arya, M.D., was developing strategies as a UAMS Translational Research Institute Implementation Science Scholar to establish statewide…

Previous page Next page